RE: Thoth16 Apr 2022 15:13
C007'' i believe CRUK is the main reason why Sierra have been
able to get away with leaving 737 on the shelf for so long
knowing how good the Data was, because they was the bigger partner
it should have been there job to chase them up, after they got that first $150m funding
3 years ago and if they continue to leave it on the shelf, they should have taken it back
a long time ago before they slip it through the back door for £50m less than the
original contract..
there was lot's of posts and conversation around CRUK taking 737 back
on this BB, as a few of us good posters could see what Sierra game was
and what was coming in a few years time, by the way they seems to leave us out
in all the RNS they put out to the Market over the years, CRUK got a mention
a few time but never Sareum,
and as i said before Sierra SP before they took over the development of SRA 737
was $1.35 and it push all the way to $11 in the first year, with lot's of Data on it
mostly SAR & CRUK data, and a little bit of there own, with conference after conferences
and because they left us out of all the write up, all the time, our SP remain flat
while they lapped up all the glory, SAR SP should have hit T2 28p target years ago
there should have never been any reason for consolidation, if just $10m of that
$150m funding call was use for P2 and pay us that £7m, we was at 2.60p at the time
and the payment should have come that Christmas, you can imagine the expectation at the time,
on this BB, if they would have put 737 into P2 and paid us, SP would have fly pass 20p IMO
we would have been closer to £1 by now'' with the momentum, and the excitement
around a cure for Cancer at the time, but ooo no'' greed had to take over, me me me
a very stupid move IMO, because now, they are selling out lot stock and barrel
to GSK FOR $1.9B when they would have got at least $20b if they would have taken
737 to P2
greed and hate on the small guys because you can never pay's
all i know, is that we don't really need to worry about 737 anymore
to give our SP a boost with the giant in 1801 / 1802 coming this year
and we don't need any sniffer's for a bid, until we get to P3 and SP closer to £25,
if 737 come good one day under the leadership of GSK it will be a huge bonus,
but for now it should be kept in the bottom draw, so it don't drive us mad, while keeping an eye
on any new GSK announcement to see if they are giving 737 a look in''
HAPPY EASTER
308..
Sign In
Follow the stocks
